Keywords: merck, kgaa, gets, lpath, asonep, deal, worth

Merck KGaA gets Lpath's Asonep in deal worth up to $422M

Article | 03 November 2008

San Diego, USA-headquartered Lpath, a developer of lipid-based therapeutics, has entered a worldwide alliance with Germany's Merck KGaA to develop ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Go to company listing